Crispr Therapeutics Ag · NASDAQ:CRSP

Kasinger James R. sold 1,040 Crispr Therapeutics Ag shares (Form 4)

Traded Oct 13 to Oct 14, 2026 · Filed Oct 15, 2026

From Oct 13 to Oct 14, 2026, Kasinger James R. (General Counsel and Secretary) sold 1,040 Crispr Therapeutics Ag shares at US$49.26 for US$51,230, leaving 95,857 shares. Filed Oct 15, 2026 (Form 4).

Sold: 1,040 shares
Price: US$49.26
Value: US$51,230
Holding after: 95,857 shares
Trading plan: No
Role: General Counsel and Secretary

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 13, 2026	Common Shares	Option exercise	2,113		96,897	Direct
Oct 14, 2026	Common Shares	Sale	1,040	US$49.26	95,857	Direct

Source

Download original · View original at SEC

Related